PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $999,800 | -8.8% | 32,588 | +19.2% | 0.12% | -12.3% |
Q2 2023 | $1,095,794 | +100.4% | 27,347 | +93.1% | 0.14% | +122.6% |
Q4 2022 | $546,872 | -2.3% | 14,164 | +41.6% | 0.06% | +44.2% |
Q3 2021 | $560,000 | -60.4% | 10,000 | -57.1% | 0.04% | -65.9% |
Q2 2021 | $1,415,000 | -6.4% | 23,326 | -7.6% | 0.13% | +11.5% |
Q4 2020 | $1,511,000 | – | 25,251 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |